ORIC icon

Oric Pharmaceuticals
ORIC

Overview Fund Activity

76 hedge funds and large institutions have $98M invested in Oric Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 17 closing their positions.

Holders
76
Holders Change
-7
Holders Change %
-8.43%
% of All Funds
1.31%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
21
Reduced
28
Closed
17
Calls
$962K
Puts
$543K
Net Calls
+$419K
Net Calls Change
-$821K

Top Buyers

1
PM
1
Prosight Management
Texas
$3M
2
SCM
2
Suvretta Capital Management
New York
$6.09M
3
BlackRock
3
BlackRock
New York
$3.32M
4
GCP
4
GSA Capital Partners
United Kingdom
$722K
5
SCM
5
Silverarc Capital Management
Massachusetts
$3.87M

Top Sellers

1
CC
1
Casdin Capital
New York
$0
2
ACH
2
ArrowMark Colorado Holdings
Colorado
$1.74M
3
Citadel Advisors
3
Citadel Advisors
Florida
$40K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Charles Schwab
5
Charles Schwab
California
$54K
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$13.9M 4,348,392 -6,790 -0.2%
CG
2
Column Group
California
$11.4M 3,568,181 – –
EC
3
EcoR1 Capital
California
$10.9M 3,418,068 – –
Alkeon Capital Management
4
Alkeon Capital Management
New York
$6.74M 2,106,968 – –
SCM
5
Suvretta Capital Management
New York
$6.09M 1,902,643 +640,179 +51%
Millennium Management
6
Millennium Management
New York
$4.89M 1,528,608 +86,631 +6%
Vanguard Group
7
Vanguard Group
Pennsylvania
$4.31M 1,346,862 -66,869 -5%
SCM
8
Silverarc Capital Management
Massachusetts
$3.87M 1,208,992 +126,688 +12%
BC
9
Boxer Capital
California
$3.37M 1,054,000 – –
BlackRock
10
BlackRock
New York
$3.32M 1,038,942 +239,601 +30%
IFA
11
Invus Financial Advisors
New York
$3.22M 1,007,575 – –
PM
12
Prosight Management
Texas
$3M 936,334 +936,334 New
EC
13
Euclidean Capital
New York
$2.39M 747,550 – –
MSKCC
14
Memorial Sloan Kettering Cancer Center
New York
$1.93M 602,272 – –
ACH
15
ArrowMark Colorado Holdings
Colorado
$1.74M 543,812 -739,346 -58%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$1.71M 533,888 +27,901 +6%
DCM
17
DAFNA Capital Management
California
$1.32M 413,526 -2,400 -0.6%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.28M 401,400 -46,469 -10%
AG
19
Artal Group
Luxembourg
$1.28M 400,000 – –
UOC
20
UBS O'Connor
Illinois
$1.1M 343,002 -18,053 -5%
MAM
21
Monaco Asset Management
Monaco
$1.09M 341,182 -23,559 -6%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$909K 284,308 -40,065 -12%
OMC
23
Oasis Management Company
Cayman Islands
$872K 272,480 – –
GCP
24
GSA Capital Partners
United Kingdom
$722K 225,600 +174,965 +346%
Two Sigma Investments
25
Two Sigma Investments
New York
$557K 174,065 -61,271 -26%
1
2 3 4